| GUERBET SA INH. EO 1 |
| Frankreich |
| Gesundheit |
| FR0000032526 / 870481 |
| 4G8 (Frankfurt) |
| FRA:4G8, ETR:4G8, 4G8:GR |
| - |
| http://www.guerbet.com/ |
|
Guerbet SA is a French pharmaceutical group specializing in the research, development, production, and sale of contrast media for medical imaging. Founded in 1926 by André Guerbet, the company traces its roots to the discovery of Lipiodol, the first..
>Volltext.. |
| 117.16 Mio. EUR |
| 432.41 Mio. EUR |
| 800.2 Mio. EUR |
| 55.65 Mio. EUR |
| -110.23 Mio. EUR |
| -8.74 EUR |
| 445.5 Mio. EUR |
| 117.55 Mio. EUR |
| 62.36 Mio. EUR |
| 0.48 |
| -6.5% |
| -773.53% |
| - |
| - |
| - |
| 01.07.24 - 0.5€ 29.06.23 - 0.5€ >weitere anzeigen... |
| - |
| GUERBET |
| 05.04.26 |
|